Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL.IS) Stock Price and Company Information, 2024
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
GENIL.IS
| Exchange: | IS |
| Currency | Turkish lira |
| ISIN: | TREGENL00024 |
| Primary Ticker: | GENIL.IS |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Pharmaceuticals |
| Gic Sub Industry: | Pharmaceuticals |
| Description: | Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration and licensing agreement with Sulfateq BV for the development and commercialization of the original molecule SUL-238 as a unique treatment for Alzheimer's disease and other neurodegenerative diseases. The company was incorporated in 1997 and is headquartered in Çankaya, Turkey. |
| Address: | Mustafa Kemal Mahallesi 2119.Sk. No:3, Çankaya, Turkey, 06520 |
| Website: | https://www.genilac.com.tr |
| Full Time Employees: | 617 |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 25020000256 |
| Market Capitalization Mln: | 25020.00 |
| EBITDA: | 1311291904 |
| PE Ratio: | 33.49 |
| Book Value: | 19.61 |
| Dividend Share: | 1.11 |
| Earnings Share: | 2.49 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.06 |
| Operating Margin TTM: | 0.07 |
| Return On Assets TTM: | 0.08 |
| Return On Equity TTM: | 0.17 |
| Revenue TTM: | 10919552000 |
| Revenue Per Share TTM: | 36.39 |
| Quarterly Revenue Growth YOY: | 0.59 |
| Gross Profit TTM: | 1137709333 |
| Diluted Eps TTM: | 2.49 |
| Quarterly Earnings Growth YOY: | 0.46 |
Valuation
| Trailing PE: | 33.49 |
| Price Sales TTM: | 2.29 |
| Price Book MRQ: | 4.24 |
| Enterprise Value: | 25760488055 |
| Enterprise Value Revenue: | 2.35 |
| Enterprise Value Ebitda: | 17.53 |
Shares
| Shares Outstanding: | 300000000 |
| Shares Float: | 67839000 |
| Percent Insiders: | 74.19 |
| Percent Institutions: | 4.14 |
Technicals
| Beta: | 1.15 |
| 52 Week High: | 94.58 |
| 52 Week Low: | 42.14 |
| 50 Day MA: | 87.93 |
| 200 Day MA: | 71.43 |
Splits & Dividends
| Forward Annual Dividend Rate: | 0.74 |
| Payout Ratio: | 0.14 |
| Ex Dividend Date: | 2024-10-08 |
Earnings
| Report Date: | 2024-06-30 |
| Date: | 2024-06-30 |
| Currency: | TRY |
| Eps Actual: | -0.60 |
| Report Date: | 2024-03-31 |
| Date: | 2024-03-31 |
| Currency: | TRY |
| Eps Actual: | 0.53 |
| Report Date: | 2023-12-31 |
| Date: | 2023-12-31 |
| Currency: | TRY |
| Eps Actual: | -0.44 |
| Report Date: | 2023-09-30 |
| Date: | 2023-09-30 |
| Currency: | TRY |
| Eps Actual: | 1.05 |
| Report Date: | 2023-06-30 |
| Date: | 2023-06-30 |
| Currency: | TRY |
| Eps Actual: | 0.55 |
| Report Date: | 2023-03-31 |
| Date: | 2023-03-31 |
| Currency: | TRY |
| Eps Actual: | 0.34 |
| Report Date: | 2022-12-31 |
| Date: | 2022-12-31 |
| Currency: | TRY |
| Eps Actual: | 1.38 |
| Report Date: | 2022-09-30 |
| Date: | 2022-09-30 |
| Currency: | TRY |
| Eps Actual: | 0.82 |
| Report Date: | 2022-06-30 |
| Date: | 2022-06-30 |
| Currency: | TRY |
| Eps Actual: | 0.83 |
| Report Date: | 2022-03-31 |
| Date: | 2022-03-31 |
| Currency: | TRY |
| Eps Actual: | 0.56 |
| Report Date: | 2021-12-31 |
| Date: | 2021-12-31 |
| Currency: | TRY |
| Eps Actual: | 0.37 |
| Report Date: | 2021-09-30 |
| Date: | 2021-09-30 |
| Currency: | TRY |
| Eps Actual: | 0.22 |
| Date: | 2024-06-30 |
| Eps Actual: | -0.06 |
| Date: | 2023-12-31 |
| Eps Actual: | 1.51 |
| Date: | 2022-12-31 |
| Eps Actual: | 3.60 |
| Date: | 2021-12-31 |
| Eps Actual: | 0.59 |